Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.

Timothy J. Wilkin, Barbara Taylor, Susan Olender, Scott M. Hammer

Producción científica: Articlerevisión exhaustiva

5 Citas (Scopus)

Resumen

The 15th Conference on Retroviruses and Opportunistic Infections maintained its place as the premier meeting for presentation of the state of the art of antiretroviral therapy. This year brought together data on new antiretroviral agents in the pipeline, updated our knowledge base of agents approved in the past year (eg, maraviroc, raltegravir, etravirine), delineated approaches to management of treatment-naive and -experienced patients and the use of drugs for prevention of maternal-to-child transmission, and refined our expanding knowledge of drug resistance. A particular highlight of this year's conference was the progress made in antiretroviral treatment and research in resource-limited settings as reflected in both the number and quality of presentations emanating from the developing world.

Idioma originalEnglish (US)
Páginas (desde-hasta)31-60
Número de páginas30
PublicaciónTopics in HIV medicine : a publication of the International AIDS Society, USA
Volumen16
N.º1
EstadoPublished - 2008
Publicado de forma externa

ASJC Scopus subject areas

  • General Medicine

Huella

Profundice en los temas de investigación de 'Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.'. En conjunto forman una huella única.

Citar esto